UNSPSC 51401541: Sarmazenil

This classification denotes an anxiolytic with the molecular formula C15H14ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F84AE7X24P, chemically known as ethyl 7-chloro-5,6-dihydro-5-methyl-6-oxo-4h-imidazo-(1,5-a)(1,4)benzodiazepine-3-carboxylate but generally known as sarmazenil, which bears US NIH Compound Identifier 71231. European Medicines Agency schedules Sarmazenil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10452MIG.

UNSPSC 51401541 Sarmazenil, a Commodity code, identifies pharmaceutical products that state and local governments procure to support emergency response and community health initiatives. Recent solicitations under this code show that issuing bodies are acquiring naloxone and related drug-deactivation systems for overdose response and substance abuse management, not sarmazenil specifically. The work involves supply agreements with recurring annual deliveries, fixed pricing, and compliance with drug-free workplace and E-Verify requirements. County health departments and community health systems represent the primary issuing bodies active under this code.

Seminole County, Florida posted the most recent documented opportunity under this code—IFB 60459723LAS, released June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding. The IFB required electronic submission by July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors were required to include all shipping and delivery costs in their bid and comply with insurance, E-Verify, and potential FEMA-related federal compliance requirements. The contract included a two-year initial term with one-year renewal option and a three-month probationary termination clause. Beyond Seminole County, the source documents limited recent activity; the code shows sparse volume in state and local procurement channels, with no additional jurisdictions or geographic clusters evident from the available opportunity record.